top of page

First-in-Class Oncology Product Launch

SITUATION

The newly appointed Chief Commercial Officer of a clinical-stage biopharmaceutical company needed to move quickly to prepare for a first-in-class oncology product launch. After receiving breakthrough therapy status for its lead indication, the company needed to build out a new commercial organization and prepare for its first ever launch in just 12 months.

OUR ROLE

We collaborated closely with the client to develop a comprehensive commercial launch plan and spearhead the launch readiness process leading up to FDA approval. Through meticulous coordination of cross-functional workstreams, we identified key dependencies, mitigated risks proactively, and supported the leadership team in critical decision-making.

IMPACT

Within a year, the client grew from a clinical-stage biopharmaceutical company with no commercial infrastructure to one with a fully-integrated commercial organization, equipped with a nationwide sales force and ready for a successful launch ahead of the anticipated FDA decision (PDUFA) date.

RELATED CASE STUDIES
Market_Opportunity_Assessment_for_GoNoGo.jpg

Market Opportunity Assessment for Go/No-Go Clinical Decision

Post-Launch Repositioning of Innovative Diagnostic

Post-Launch_Repositioning_of_Innovative_Diagnostic.jpg

Learn more about our experience

bottom of page